Tadalafil Therapy for Pulmonary Arterial Hypertension (vol 119, pg 2894, 2009)

被引：7
|
作者：
Galie
机构：
来源：
CIRCULATION | 2011年 / 124卷 / 10期
关键词：
D O I：
10.1161/CIR.0b013e318231bed1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E279 / E279
页数：1
相关论文
共 50 条
  • [41] Therapy of pulmonary arterial hypertension
    Olschewski, H
    Ghofrani, A
    Enke, B
    Reichenberger, F
    Voswinckel, R
    Kreckel, A
    Ghofrani, S
    Wiedemann, R
    Schulz, R
    Grimminger, F
    Seeger, W
    INTERNIST, 2005, 46 (03): : 341 - +
  • [42] Therapy of pulmonary arterial hypertension
    Voswinckel, R.
    Reichenberger, F.
    Gall, H.
    Seeger, W.
    Grimminger, F.
    Ghofrani, H. A.
    INTERNIST, 2009, 50 (09): : 1101 - +
  • [43] Therapy of Pulmonary Arterial Hypertension
    Klose, H.
    Harbaum, L.
    Oqueka, T.
    Simon, M.
    Gruenig, E.
    PNEUMOLOGIE, 2015, 69 (08): : 483 - 495
  • [44] Endothelin receptor blockade in the management of pulmonary arterial hypertension: Selective and dual antagonism (vol 103, pg 951, 2009)
    Trow, Terence K.
    Taichman, Darren B.
    RESPIRATORY MEDICINE, 2013, 107 (09) : 1463 - 1463
  • [45] Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension
    Hassoun, Paul M.
    Zamanian, Roham T.
    Damico, Rachel
    Lechtzin, Noah
    Khair, Rubina
    Kolb, Todd M.
    Tedford, Ryan J.
    Hulme, Olivia L.
    Housten, Traci
    Pisanello, Chiara
    Sato, Takahiro
    Pullins, Erica H.
    Corona-Villalobos, Celia P.
    Zimmerman, Stefan L.
    Gashouta, Mohamed A.
    Minai, Omar A.
    Torres, Fernando
    Girgis, Reda E.
    Chin, Kelly
    Mathai, Stephen C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 192 (09) : 1102 - 1110
  • [46] Randomized study of adding tadalafil to existing ambrisentan in pulmonary arterial hypertension
    Yugang Zhuang
    Bojie Jiang
    Hui Gao
    Wei Zhao
    Hypertension Research, 2014, 37 : 507 - 512
  • [47] Tadalafil: the evidence for its clinical potential in the treatment of pulmonary arterial hypertension
    Katz, Stuart D.
    CORE EVIDENCE, 2007, 2 (04) : 225 - 231
  • [48] Conversion From Sildenafil to Tadalafil: Results From the Sildenafil to Tadalafil in Pulmonary Arterial Hypertension (SITAR) Study
    Frantz, Robert P.
    Durst, Louise
    Burger, Charles D.
    Oudiz, Ronald J.
    Bourge, Robert C.
    Franco, Veronica
    Waxman, Aaron B.
    McDevitt, Susanne
    Walker, Susan
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2014, 19 (06) : 550 - 557
  • [49] Sildenafil and tadalafil, a new option in the treatment of patients with pulmonary arterial hypertension
    Konorza, T.
    Haude, M.
    Kaelsch, H.
    Neudorf, U.
    Katz, M.
    Neumann, T.
    Erbel, R.
    EUROPEAN HEART JOURNAL, 2005, 26 : 78 - 78
  • [50] Sildenafil to Tadalafil Transition in Patients with Pulmonary Arterial Hypertension: A Retrospective Review
    Shlobin, O. A.
    Brown, A. W.
    Weir, N.
    Merte, L.
    Ahmad, S.
    Brown, K.
    Nathan, S. D.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2011, 30 (04) : S72 - S72
12345